Industry Research Reports
Home > Reports > Medical Devices & Consumables > Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-02-25
Pages: 159 Pages
Report ld: 4282103
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Sterile Lancets Market Size(US$)
CAGR 2025-2031
4.6%
Market Size,2031
USD 2,288
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,744 million
Market Forecast in 2031(Value)
US$ 2,288 million
CAGR
4.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Sterile Lancets was estimated to be worth US$ 1674 million in 2024 and is forecast to a readjusted size of US$ 2288 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Market Drivers:
Growing prevalence of chronic diseases: The rise in chronic conditions like diabetes, which require regular blood glucose monitoring, is a significant driver for lancet demand. As the number of diabetes patients increases globally, the need for Sterile Lancets continues to grow.
Technological advancements in Sterile Lancets: Innovations such as ultra-thin needles, painless lancet designs, and easy-to-use lancet devices improve user experience, making blood sampling more comfortable and encouraging more frequent use.
Increase in home-based healthcare: The trend toward home healthcare and self-monitoring for various conditions, especially diabetes, has driven the use of Sterile Lancets. This allows patients to monitor their health in a more convenient and cost-effective way, increasing the market for these devices.
Aging population: The growing elderly population is more prone to chronic diseases like diabetes, requiring regular blood monitoring. This demographic shift is a major factor pushing the demand for Sterile Lancets and other monitoring devices.
Rising awareness of preventive healthcare: Increasing awareness of the importance of regular health monitoring, especially for managing conditions like diabetes, has led to higher adoption of Sterile Lancets for routine blood tests and glucose monitoring.
Market Challenges:
Competition from alternative technologies: Non-invasive blood glucose monitoring methods (such as continuous glucose monitors or sensor-based systems) are gaining traction, potentially reducing the reliance on traditional Sterile Lancets for blood sampling.
High recurring costs for patients: Sterile Lancets are single-use devices, and the recurring cost for people who need frequent testing can become a financial burden, particularly in low-income regions or for uninsured patients, limiting market growth.
Infection risks: Improper or repeated use of Sterile Lancets can lead to infections, particularly if they are not disposed of properly or if reused by mistake, which poses a health risk and deters their use.
Environmental concerns: Sterile Lancets contribute to medical waste, as they are disposable devices, raising concerns about environmental impact. This could lead to regulatory pressures or a shift toward more sustainable alternatives.
Regulatory compliance and approval hurdles: The lancet market is subject to stringent regulations and approval processes from health authorities. This can slow down the introduction of new products and innovations, delaying their availability in the market.
The classification of Sterile Lancets includes Ordinary Sterile Lancets and Safety Sterile Lancets. In 2023, Ordinary Sterile Lancets accounted for a share of 61.81% in the global Sterile Lancets market. With several hospitals and healthcare facilities converting to safety Sterile Lancets, this market share is poised for declined. Americas is the largest consumption place, with a consumption market share nearly 40 % in 2022. Following Americas, Europe is the second largest consumption place with the consumption market share of 30 %.
This report aims to provide a comprehensive presentation of the global market for Sterile Lancets, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sterile Lancets by region & country, by Type, and by Application.
The Sterile Lancets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Lancets.
MARKET SEGMENTATION
By Company
- Roche
- Lifescan
- BD
- Ascensia
- Abbott
- B. Braun
- ARKRAY
- Terumo
- I-SENS
- Nipro
- Cardinal Health
- ICU Medical
- Sarstedt
- Sinocare
- Yicheng
- Yuwell
- Greiner Bio One
- Guangzhou iCare Medical
- Shandong Lianfa
- Tianjin Huahong
- Owen Mumford
- HemoCue
- HTL-STREFA
- UltiMed
- SteriLance Medical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Safety Lancets
- Ordinary Lancets
Segment by Application
- Children's Fingertip Blood Tests
- Glucose Tests
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sterile Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sterile Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sterile Lancets in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Sterile Lancets Product Introduction
1.2 Global Sterile Lancets Market Size Forecast
1.2.1 Global Sterile Lancets Sales Value (2020-2031)
1.2.2 Global Sterile Lancets Sales Volume (2020-2031)
1.2.3 Global Sterile Lancets Sales Price (2020-2031)
1.3 Sterile Lancets Market Trends & Drivers
1.3.1 Sterile Lancets Industry Trends
1.3.2 Sterile Lancets Market Drivers & Opportunity
1.3.3 Sterile Lancets Market Challenges
1.3.4 Sterile Lancets Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sterile Lancets Players Revenue Ranking (2024)
2.2 Global Sterile Lancets Revenue by Company (2020-2025)
2.3 Global Sterile Lancets Players Sales Volume Ranking (2024)
2.4 Global Sterile Lancets Sales Volume by Company Players (2020-2025)
2.5 Global Sterile Lancets Average Price by Company (2020-2025)
2.6 Key Manufacturers Sterile Lancets Manufacturing Base and Headquarters
2.7 Key Manufacturers Sterile Lancets Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sterile Lancets
2.9 Sterile Lancets Market Competitive Analysis
2.9.1 Sterile Lancets Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Sterile Lancets Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Lancets as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Safety Lancets
3.1.2 Ordinary Lancets
3.2 Global Sterile Lancets Sales Value by Type
3.2.1 Global Sterile Lancets Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Sterile Lancets Sales Value, by Type (2020-2031)
3.2.3 Global Sterile Lancets Sales Value, by Type (%) (2020-2031)
3.3 Global Sterile Lancets Sales Volume by Type
3.3.1 Global Sterile Lancets Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Sterile Lancets Sales Volume, by Type (2020-2031)
3.3.3 Global Sterile Lancets Sales Volume, by Type (%) (2020-2031)
3.4 Global Sterile Lancets Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Children's Fingertip Blood Tests
4.1.2 Glucose Tests
4.1.3 Others
4.2 Global Sterile Lancets Sales Value by Application
4.2.1 Global Sterile Lancets Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Sterile Lancets Sales Value, by Application (2020-2031)
4.2.3 Global Sterile Lancets Sales Value, by Application (%) (2020-2031)
4.3 Global Sterile Lancets Sales Volume by Application
4.3.1 Global Sterile Lancets Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Sterile Lancets Sales Volume, by Application (2020-2031)
4.3.3 Global Sterile Lancets Sales Volume, by Application (%) (2020-2031)
4.4 Global Sterile Lancets Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Sterile Lancets Sales Value by Region
5.1.1 Global Sterile Lancets Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Sterile Lancets Sales Value by Region (2020-2025)
5.1.3 Global Sterile Lancets Sales Value by Region (2026-2031)
5.1.4 Global Sterile Lancets Sales Value by Region (%), (2020-2031)
5.2 Global Sterile Lancets Sales Volume by Region
5.2.1 Global Sterile Lancets Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Sterile Lancets Sales Volume by Region (2020-2025)
5.2.3 Global Sterile Lancets Sales Volume by Region (2026-2031)
5.2.4 Global Sterile Lancets Sales Volume by Region (%), (2020-2031)
5.3 Global Sterile Lancets Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Sterile Lancets Sales Value, 2020-2031
5.4.2 North America Sterile Lancets Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Sterile Lancets Sales Value, 2020-2031
5.5.2 Europe Sterile Lancets Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Sterile Lancets Sales Value, 2020-2031
5.6.2 Asia Pacific Sterile Lancets Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Sterile Lancets Sales Value, 2020-2031
5.7.2 South America Sterile Lancets Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sterile Lancets Sales Value, 2020-2031
5.8.2 Middle East & Africa Sterile Lancets Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sterile Lancets Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Sterile Lancets Sales Value
6.2.1 Key Countries/Regions Sterile Lancets Sales Value, 2020-2031
6.2.2 Key Countries/Regions Sterile Lancets Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Sterile Lancets Sales Value, 2020-2031
6.3.2 United States Sterile Lancets Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Sterile Lancets Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Sterile Lancets Sales Value, 2020-2031
6.4.2 Europe Sterile Lancets Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Sterile Lancets Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Sterile Lancets Sales Value, 2020-2031
6.5.2 China Sterile Lancets Sales Value by Type (%), 2024 VS 2031
6.5.3 China Sterile Lancets Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Sterile Lancets Sales Value, 2020-2031
6.6.2 Japan Sterile Lancets Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Sterile Lancets Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Sterile Lancets Sales Value, 2020-2031
6.7.2 South Korea Sterile Lancets Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Sterile Lancets Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Sterile Lancets Sales Value, 2020-2031
6.8.2 Southeast Asia Sterile Lancets Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Sterile Lancets Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Sterile Lancets Sales Value, 2020-2031
6.9.2 India Sterile Lancets Sales Value by Type (%), 2024 VS 2031
6.9.3 India Sterile Lancets Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Roche Sterile Lancets Product Offerings
7.1.5 Roche Recent Development
7.2 Lifescan
7.2.1 Lifescan Company Information
7.2.2 Lifescan Introduction and Business Overview
7.2.3 Lifescan Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Lifescan Sterile Lancets Product Offerings
7.2.5 Lifescan Recent Development
7.3 BD
7.3.1 BD Company Information
7.3.2 BD Introduction and Business Overview
7.3.3 BD Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 BD Sterile Lancets Product Offerings
7.3.5 BD Recent Development
7.4 Ascensia
7.4.1 Ascensia Company Information
7.4.2 Ascensia Introduction and Business Overview
7.4.3 Ascensia Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Ascensia Sterile Lancets Product Offerings
7.4.5 Ascensia Recent Development
7.5 Abbott
7.5.1 Abbott Company Information
7.5.2 Abbott Introduction and Business Overview
7.5.3 Abbott Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Abbott Sterile Lancets Product Offerings
7.5.5 Abbott Recent Development
7.6 B. Braun
7.6.1 B. Braun Company Information
7.6.2 B. Braun Introduction and Business Overview
7.6.3 B. Braun Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 B. Braun Sterile Lancets Product Offerings
7.6.5 B. Braun Recent Development
7.7 ARKRAY
7.7.1 ARKRAY Company Information
7.7.2 ARKRAY Introduction and Business Overview
7.7.3 ARKRAY Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 ARKRAY Sterile Lancets Product Offerings
7.7.5 ARKRAY Recent Development
7.8 Terumo
7.8.1 Terumo Company Information
7.8.2 Terumo Introduction and Business Overview
7.8.3 Terumo Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Terumo Sterile Lancets Product Offerings
7.8.5 Terumo Recent Development
7.9 I-SENS
7.9.1 I-SENS Company Information
7.9.2 I-SENS Introduction and Business Overview
7.9.3 I-SENS Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 I-SENS Sterile Lancets Product Offerings
7.9.5 I-SENS Recent Development
7.10 Nipro
7.10.1 Nipro Company Information
7.10.2 Nipro Introduction and Business Overview
7.10.3 Nipro Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Nipro Sterile Lancets Product Offerings
7.10.5 Nipro Recent Development
7.11 Cardinal Health
7.11.1 Cardinal Health Company Information
7.11.2 Cardinal Health Introduction and Business Overview
7.11.3 Cardinal Health Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Cardinal Health Sterile Lancets Product Offerings
7.11.5 Cardinal Health Recent Development
7.12 ICU Medical
7.12.1 ICU Medical Company Information
7.12.2 ICU Medical Introduction and Business Overview
7.12.3 ICU Medical Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 ICU Medical Sterile Lancets Product Offerings
7.12.5 ICU Medical Recent Development
7.13 Sarstedt
7.13.1 Sarstedt Company Information
7.13.2 Sarstedt Introduction and Business Overview
7.13.3 Sarstedt Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Sarstedt Sterile Lancets Product Offerings
7.13.5 Sarstedt Recent Development
7.14 Sinocare
7.14.1 Sinocare Company Information
7.14.2 Sinocare Introduction and Business Overview
7.14.3 Sinocare Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Sinocare Sterile Lancets Product Offerings
7.14.5 Sinocare Recent Development
7.15 Yicheng
7.15.1 Yicheng Company Information
7.15.2 Yicheng Introduction and Business Overview
7.15.3 Yicheng Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Yicheng Sterile Lancets Product Offerings
7.15.5 Yicheng Recent Development
7.16 Yuwell
7.16.1 Yuwell Company Information
7.16.2 Yuwell Introduction and Business Overview
7.16.3 Yuwell Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Yuwell Sterile Lancets Product Offerings
7.16.5 Yuwell Recent Development
7.17 Greiner Bio One
7.17.1 Greiner Bio One Company Information
7.17.2 Greiner Bio One Introduction and Business Overview
7.17.3 Greiner Bio One Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Greiner Bio One Sterile Lancets Product Offerings
7.17.5 Greiner Bio One Recent Development
7.18 Guangzhou iCare Medical
7.18.1 Guangzhou iCare Medical Company Information
7.18.2 Guangzhou iCare Medical Introduction and Business Overview
7.18.3 Guangzhou iCare Medical Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Guangzhou iCare Medical Sterile Lancets Product Offerings
7.18.5 Guangzhou iCare Medical Recent Development
7.19 Shandong Lianfa
7.19.1 Shandong Lianfa Company Information
7.19.2 Shandong Lianfa Introduction and Business Overview
7.19.3 Shandong Lianfa Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Shandong Lianfa Sterile Lancets Product Offerings
7.19.5 Shandong Lianfa Recent Development
7.20 Tianjin Huahong
7.20.1 Tianjin Huahong Company Information
7.20.2 Tianjin Huahong Introduction and Business Overview
7.20.3 Tianjin Huahong Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Tianjin Huahong Sterile Lancets Product Offerings
7.20.5 Tianjin Huahong Recent Development
7.21 Owen Mumford
7.21.1 Owen Mumford Company Information
7.21.2 Owen Mumford Introduction and Business Overview
7.21.3 Owen Mumford Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Owen Mumford Sterile Lancets Product Offerings
7.21.5 Owen Mumford Recent Development
7.22 HemoCue
7.22.1 HemoCue Company Information
7.22.2 HemoCue Introduction and Business Overview
7.22.3 HemoCue Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.22.4 HemoCue Sterile Lancets Product Offerings
7.22.5 HemoCue Recent Development
7.23 HTL-STREFA
7.23.1 HTL-STREFA Company Information
7.23.2 HTL-STREFA Introduction and Business Overview
7.23.3 HTL-STREFA Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.23.4 HTL-STREFA Sterile Lancets Product Offerings
7.23.5 HTL-STREFA Recent Development
7.24 UltiMed
7.24.1 UltiMed Company Information
7.24.2 UltiMed Introduction and Business Overview
7.24.3 UltiMed Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.24.4 UltiMed Sterile Lancets Product Offerings
7.24.5 UltiMed Recent Development
7.25 SteriLance Medical
7.25.1 SteriLance Medical Company Information
7.25.2 SteriLance Medical Introduction and Business Overview
7.25.3 SteriLance Medical Sterile Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.25.4 SteriLance Medical Sterile Lancets Product Offerings
7.25.5 SteriLance Medical Recent Development
8 Industry Chain Analysis
8.1 Sterile Lancets Industrial Chain
8.2 Sterile Lancets Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sterile Lancets Sales Model
8.5.2 Sales Channel
8.5.3 Sterile Lancets Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Sterile Lancets Market Trends
Table 2. Sterile Lancets Market Drivers & Opportunity
Table 3. Sterile Lancets Market Challenges
Table 4. Sterile Lancets Market Restraints
Table 5. Global Sterile Lancets Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Sterile Lancets Revenue Market Share by Company (2020-2025)
Table 7. Global Sterile Lancets Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Sterile Lancets Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Sterile Lancets Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Sterile Lancets Manufacturing Base and Headquarters
Table 11. Key Manufacturers Sterile Lancets Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Sterile Lancets
Table 13. Global Sterile Lancets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Lancets as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Sterile Lancets Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Sterile Lancets Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Sterile Lancets Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Sterile Lancets Sales Market Share in Value by Type (2020-2025)
Table 20. Global Sterile Lancets Sales Market Share in Value by Type (2026-2031)
Table 21. Global Sterile Lancets Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Sterile Lancets Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Sterile Lancets Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Sterile Lancets Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Sterile Lancets Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Sterile Lancets Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Sterile Lancets Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Sterile Lancets Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Sterile Lancets Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Sterile Lancets Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Sterile Lancets Sales Market Share in Value by Application (2020-2025)
Table 32. Global Sterile Lancets Sales Market Share in Value by Application (2026-2031)
Table 33. Global Sterile Lancets Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Sterile Lancets Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Sterile Lancets Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Sterile Lancets Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Sterile Lancets Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Sterile Lancets Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Sterile Lancets Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Sterile Lancets Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Sterile Lancets Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Sterile Lancets Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Sterile Lancets Sales Value by Region (2020-2025) & (%)
Table 44. Global Sterile Lancets Sales Value by Region (2026-2031) & (%)
Table 45. Global Sterile Lancets Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Sterile Lancets Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Sterile Lancets Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Sterile Lancets Sales Volume by Region (2020-2025) & (%)
Table 49. Global Sterile Lancets Sales Volume by Region (2026-2031) & (%)
Table 50. Global Sterile Lancets Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Sterile Lancets Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Sterile Lancets Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Sterile Lancets Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Sterile Lancets Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Sterile Lancets Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Sterile Lancets Sales Volume, (2026-2031) & (K Units)
Table 57. Roche Company Information
Table 58. Roche Introduction and Business Overview
Table 59. Roche Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Roche Sterile Lancets Product Offerings
Table 61. Roche Recent Development
Table 62. Lifescan Company Information
Table 63. Lifescan Introduction and Business Overview
Table 64. Lifescan Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Lifescan Sterile Lancets Product Offerings
Table 66. Lifescan Recent Development
Table 67. BD Company Information
Table 68. BD Introduction and Business Overview
Table 69. BD Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. BD Sterile Lancets Product Offerings
Table 71. BD Recent Development
Table 72. Ascensia Company Information
Table 73. Ascensia Introduction and Business Overview
Table 74. Ascensia Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Ascensia Sterile Lancets Product Offerings
Table 76. Ascensia Recent Development
Table 77. Abbott Company Information
Table 78. Abbott Introduction and Business Overview
Table 79. Abbott Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Abbott Sterile Lancets Product Offerings
Table 81. Abbott Recent Development
Table 82. B. Braun Company Information
Table 83. B. Braun Introduction and Business Overview
Table 84. B. Braun Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. B. Braun Sterile Lancets Product Offerings
Table 86. B. Braun Recent Development
Table 87. ARKRAY Company Information
Table 88. ARKRAY Introduction and Business Overview
Table 89. ARKRAY Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. ARKRAY Sterile Lancets Product Offerings
Table 91. ARKRAY Recent Development
Table 92. Terumo Company Information
Table 93. Terumo Introduction and Business Overview
Table 94. Terumo Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Terumo Sterile Lancets Product Offerings
Table 96. Terumo Recent Development
Table 97. I-SENS Company Information
Table 98. I-SENS Introduction and Business Overview
Table 99. I-SENS Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. I-SENS Sterile Lancets Product Offerings
Table 101. I-SENS Recent Development
Table 102. Nipro Company Information
Table 103. Nipro Introduction and Business Overview
Table 104. Nipro Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Nipro Sterile Lancets Product Offerings
Table 106. Nipro Recent Development
Table 107. Cardinal Health Company Information
Table 108. Cardinal Health Introduction and Business Overview
Table 109. Cardinal Health Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Cardinal Health Sterile Lancets Product Offerings
Table 111. Cardinal Health Recent Development
Table 112. ICU Medical Company Information
Table 113. ICU Medical Introduction and Business Overview
Table 114. ICU Medical Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. ICU Medical Sterile Lancets Product Offerings
Table 116. ICU Medical Recent Development
Table 117. Sarstedt Company Information
Table 118. Sarstedt Introduction and Business Overview
Table 119. Sarstedt Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Sarstedt Sterile Lancets Product Offerings
Table 121. Sarstedt Recent Development
Table 122. Sinocare Company Information
Table 123. Sinocare Introduction and Business Overview
Table 124. Sinocare Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Sinocare Sterile Lancets Product Offerings
Table 126. Sinocare Recent Development
Table 127. Yicheng Company Information
Table 128. Yicheng Introduction and Business Overview
Table 129. Yicheng Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Yicheng Sterile Lancets Product Offerings
Table 131. Yicheng Recent Development
Table 132. Yuwell Company Information
Table 133. Yuwell Introduction and Business Overview
Table 134. Yuwell Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Yuwell Sterile Lancets Product Offerings
Table 136. Yuwell Recent Development
Table 137. Greiner Bio One Company Information
Table 138. Greiner Bio One Introduction and Business Overview
Table 139. Greiner Bio One Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Greiner Bio One Sterile Lancets Product Offerings
Table 141. Greiner Bio One Recent Development
Table 142. Guangzhou iCare Medical Company Information
Table 143. Guangzhou iCare Medical Introduction and Business Overview
Table 144. Guangzhou iCare Medical Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 145. Guangzhou iCare Medical Sterile Lancets Product Offerings
Table 146. Guangzhou iCare Medical Recent Development
Table 147. Shandong Lianfa Company Information
Table 148. Shandong Lianfa Introduction and Business Overview
Table 149. Shandong Lianfa Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 150. Shandong Lianfa Sterile Lancets Product Offerings
Table 151. Shandong Lianfa Recent Development
Table 152. Tianjin Huahong Company Information
Table 153. Tianjin Huahong Introduction and Business Overview
Table 154. Tianjin Huahong Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 155. Tianjin Huahong Sterile Lancets Product Offerings
Table 156. Tianjin Huahong Recent Development
Table 157. Owen Mumford Company Information
Table 158. Owen Mumford Introduction and Business Overview
Table 159. Owen Mumford Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 160. Owen Mumford Sterile Lancets Product Offerings
Table 161. Owen Mumford Recent Development
Table 162. HemoCue Company Information
Table 163. HemoCue Introduction and Business Overview
Table 164. HemoCue Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 165. HemoCue Sterile Lancets Product Offerings
Table 166. HemoCue Recent Development
Table 167. HTL-STREFA Company Information
Table 168. HTL-STREFA Introduction and Business Overview
Table 169. HTL-STREFA Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 170. HTL-STREFA Sterile Lancets Product Offerings
Table 171. HTL-STREFA Recent Development
Table 172. UltiMed Company Information
Table 173. UltiMed Introduction and Business Overview
Table 174. UltiMed Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 175. UltiMed Sterile Lancets Product Offerings
Table 176. UltiMed Recent Development
Table 177. SteriLance Medical Company Information
Table 178. SteriLance Medical Introduction and Business Overview
Table 179. SteriLance Medical Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 180. SteriLance Medical Sterile Lancets Product Offerings
Table 181. SteriLance Medical Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Sterile Lancets Downstream Customers
Table 185. Sterile Lancets Distributors List
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Sterile Lancets Product Picture
Figure 2. Global Sterile Lancets Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Sterile Lancets Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Sterile Lancets Sales Volume (2020-2031) & (K Units)
Figure 5. Global Sterile Lancets Sales Price (2020-2031) & (US$/Unit)
Figure 6. Sterile Lancets Report Years Considered
Figure 7. Global Sterile Lancets Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Sterile Lancets Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sterile Lancets Revenue in 2024
Figure 10. Sterile Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Safety Lancets Picture
Figure 12. Ordinary Lancets Picture
Figure 13. Global Sterile Lancets Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Sterile Lancets Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Sterile Lancets Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 16. Global Sterile Lancets Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Sterile Lancets Price by Type (2020-2031) & (US$/Unit)
Figure 18. Product Picture of Children's Fingertip Blood Tests
Figure 19. Product Picture of Glucose Tests
Figure 20. Product Picture of Others
Figure 21. Global Sterile Lancets Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Sterile Lancets Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Sterile Lancets Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 24. Global Sterile Lancets Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Sterile Lancets Price by Application (2020-2031) & (US$/Unit)
Figure 26. North America Sterile Lancets Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Sterile Lancets Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Sterile Lancets Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Sterile Lancets Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Sterile Lancets Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Sterile Lancets Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Sterile Lancets Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Sterile Lancets Sales Volume (%), (2020-2031)
Figure 38. United States Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Sterile Lancets Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Sterile Lancets Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Sterile Lancets Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Sterile Lancets Sales Value by Application (%), 2024 VS 2031
Figure 44. China Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Sterile Lancets Sales Value by Type (%), 2024 VS 2031
Figure 46. China Sterile Lancets Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Sterile Lancets Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Sterile Lancets Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Sterile Lancets Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Sterile Lancets Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Sterile Lancets Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Sterile Lancets Sales Value by Application (%), 2024 VS 2031
Figure 56. India Sterile Lancets Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Sterile Lancets Sales Value by Type (%), 2024 VS 2031
Figure 58. India Sterile Lancets Sales Value by Application (%), 2024 VS 2031
Figure 59. Sterile Lancets Industrial Chain
Figure 60. Sterile Lancets Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 4.6% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Sterile Lancets market size from 2025 to 2031?
What was the global market size of Sterile Lancets in 2031?
What was the global market size of Sterile Lancets in 2025?
Which companies rank high in the global Sterile Lancets market?
Related Reports
Global Sterile Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Sterile Lancets market size was US$ 1744 million in 2025 and is forecast to reach a readjusted size of US$ 2383 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 114
USD 4250.00
(Single User License)
Global Sterile Lancets Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Sterile Lancets market is projected to grow from US$ 1744 million in 2025 to US$ 2383 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 188
USD 4900.00
(Single User License)
Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sterile Lancets was estimated to be worth US$ 1744 million in 2025 and is projected to reach US$ 2383 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 169
USD 3950.00
(Single User License)
Global Sterile Lancets Market Research Report 2026
The global Sterile Lancets market was valued at US$ 1744 million in 2025 and is anticipated to reach US$ 2383 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 145
USD 2900.00
(Single User License)
Global Sterile Lancets Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sterile Lancets market is projected to grow from US$ 1674 million in 2024 to US$ 2288 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 182
USD 4900.00
(Single User License)
Global Sterile Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sterile Lancets market size was US$ 1674 million in 2024 and is forecast to a readjusted size of US$ 2288 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 115
USD 4250.00
(Single User License)
Global Sterile Lancets Market Research Report 2025
The global market for Sterile Lancets was valued at US$ 1674 million in the year 2024 and is projected to reach a revised size of US$ 2288 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published Date: 2025-02-25
Pages: 117
USD 2900.00
(Single User License)
Global and China Sterile Lancets Market Report & Forecast 2024-2030
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Published Date: 2024-10-23
Pages: 173
USD 4350.00
(Single User License)
Global Sterile Lancets Market Insights, Forecast to 2030
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Published Date: 2024-10-23
Pages: 198
USD 4900.00
(Single User License)
Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Published Date: 2024-10-23
Pages: 169
USD 3950.00
(Single User License)
Global Sterile Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Sterile Lancets market size was US$ 1744 million in 2025 and is forecast to reach a readjusted size of US$ 2383 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 114
USD 4250.00 (Single User License)Global Sterile Lancets Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Sterile Lancets market is projected to grow from US$ 1744 million in 2025 to US$ 2383 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 188
USD 4900.00 (Single User License)Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sterile Lancets was estimated to be worth US$ 1744 million in 2025 and is projected to reach US$ 2383 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-05
Pages: 169
USD 3950.00 (Single User License)Global Sterile Lancets Market Research Report 2026
The global Sterile Lancets market was valued at US$ 1744 million in 2025 and is anticipated to reach US$ 2383 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-05
Pages: 145
USD 2900.00 (Single User License)Global Sterile Lancets Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sterile Lancets market is projected to grow from US$ 1674 million in 2024 to US$ 2288 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 182
USD 4900.00 (Single User License)Global Sterile Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sterile Lancets market size was US$ 1674 million in 2024 and is forecast to a readjusted size of US$ 2288 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 115
USD 4250.00 (Single User License)Global Sterile Lancets Market Research Report 2025
The global market for Sterile Lancets was valued at US$ 1674 million in the year 2024 and is projected to reach a revised size of US$ 2288 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published: 2025-02-25
Pages: 117
USD 2900.00 (Single User License)Global and China Sterile Lancets Market Report & Forecast 2024-2030
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Published: 2024-10-23
Pages: 173
USD 4350.00 (Single User License)Global Sterile Lancets Market Insights, Forecast to 2030
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Published: 2024-10-23
Pages: 198
USD 4900.00 (Single User License)Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Published: 2024-10-23
Pages: 169
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now